David A. Siegel Bio Restorative Therapies, Inc. Transaction History

Two Sigma Advisers, LP

  • $41.3 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$1.74 - $2.28 $8,526 - $11,171
-4,900 Reduced 19.92%
19,700 $34,000
Q3 2023

Nov 14, 2023
SELL
$1.45 - $4.57 $2,465 - $7,769
-1,700 Reduced 6.46%
24,600 $44,000
Q2 2023

Aug 14, 2023
SELL
$3.49 - $6.49 $9,772 - $18,172
-2,800 Reduced 9.62%
26,300 $115,000
Q1 2023

May 15, 2023
BUY
$2.67 - $3.61 $77,697 - $105,051
29,100 New
29,100 $98,000

Others Institutions Holding BRTX

# of Institutions
17
Shares Held
270K
Call Options Held
0
Put Options Held
0
View Full List

About BioRestorative Therapies, Inc.

BRTX Quotes by TradingView
  • Ticker BRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 3,650,030
  • Market Cap $5.44M
  • Description
  • BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program (brtx...
More about BRTX
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email